ConductScience.org, home

Paper23717166

Characterizing a full spectrum of physico-chemical properties of (20S)- and (20R)-ginsenoside Rg3 to be proposed as standard reference materials.

Kim IW and 5 others. J Ginseng Res, 2013. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Characterizing a full spectrum of physico-chemical properties of (20S)- and (20R)-ginsenoside Rg3 to be proposed as standard reference materials. Papers, record 23717166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23717166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterizing a full spectrum of physico-chemical properties of (20S)- and (20R)-ginsenoside Rg3 to be proposed as standard reference materials.
PubMed
Journal
J Ginseng Res
PubMed
Year
2013
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1
iCite
Revised in PubMed
2022-03-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kim IWIl-Woung
2Sun WSWon Suk
3Yun BSBong-Sik
4Kim NRNa-Ri
5Min DDongsun
6Kim SKSi-Kwan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References6

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112882549Microbial transformation of ginsenoside Rb1 by Rhizopus stolonifer and Curvularia lunata.Biotechnol Lett2003https://conductscience.org/library/papers/12882549PubMed
216924497In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng.Cancer Chemother Pharmacol2007https://conductscience.org/library/papers/16924497PubMed
323717084Trends in ginseng research in 2010.J Ginseng Res2011https://conductscience.org/library/papers/23717084PubMed
423717112Recent methodology in ginseng analysis.J Ginseng Res2012https://conductscience.org/library/papers/23717112PubMed
515015374[Studies on saponin constituents in roots of Panax quinquefolium].Zhongguo Zhong Yao Za Zhi2003https://conductscience.org/library/papers/15015374PubMed
623717099Chemical Diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng.J Ginseng Res2012https://conductscience.org/library/papers/23717099PubMed

Download CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
38533264Korean red ginseng extract prevents bone loss in an oral model of glucocorticoid induced osteoporosis in mice.Front Pharmacol2024https://conductscience.org/library/papers/38533264PubMed
38476209Unveiling the experimental proof of the anticancer potential of ginsenoside Rg3 (Review).Oncol Lett2024https://conductscience.org/library/papers/38476209PubMed
38465219The pharmacological role of Ginsenoside Rg3 in liver diseases: A review on molecular mechanisms.J Ginseng Res2024https://conductscience.org/library/papers/38465219PubMed
38441023Ginsenoside Rg3: A Review of its Anticancer Mechanisms and Potential Therapeutic Applications.Curr Top Med Chem2024https://conductscience.org/library/papers/38441023PubMed
37764511Photoprotective Effects of Processed Ginseng Leaf Administration against UVB-Induced Skin Damage in Hairless Mice.Molecules2023https://conductscience.org/library/papers/37764511PubMed
37749560Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer.Chin Med2023https://conductscience.org/library/papers/37749560PubMed
35600861Chinese Herbal Medicine for Primary Liver Cancer Therapy: Perspectives and Challenges.Front Pharmacol2022https://conductscience.org/library/papers/35600861PubMed
32161549Relationship Between Ginsenoside Rg3 and Metabolic Syndrome.Front Pharmacol2020https://conductscience.org/library/papers/32161549PubMed
30344431A comparative study on immune-stimulatory and antioxidant activities of various types of ginseng extracts in murine and rodent models.J Ginseng Res2018https://conductscience.org/library/papers/30344431PubMed
28701863Inhibition of hypoxia-induced cyclooxygenase-2 by Korean Red Ginseng is dependent on peroxisome proliferator-activated receptor gamma.J Ginseng Res2017https://conductscience.org/library/papers/28701863PubMed
28287442A Strategy for Simultaneous Isolation of Less Polar Ginsenosides, Including a Pair of New 20-Methoxyl Isomers, from Flower Buds of Panax ginseng.Molecules2017https://conductscience.org/library/papers/28287442PubMed
26045689Anti-inflammatory activity of AP-SF, a ginsenoside-enriched fraction, from Korean ginseng.J Ginseng Res2015https://conductscience.org/library/papers/26045689PubMed
25535478Molecular mechanism of protopanaxadiol saponin fraction-mediated anti-inflammatory actions.J Ginseng Res2015https://conductscience.org/library/papers/25535478PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23717166

GET https://conductscience.org/api/papers/v1/23717166/authors